-+ 0.00%
-+ 0.00%
-+ 0.00%

Accord Healthcare's Hypertension Drug Wins European Medicines Agency's Positive Opinion

MT Newswires·07/24/2026 07:31:28
Listen to the news
07:31 AM EDT, 07/24/2026 (MT Newswires) -- UK-based Accord Healthcare's hypertension drug Riociguat Accord was recommended for approval by the European Medicines Agency's Committee for Medicinal Products for Human Use, according to a Friday notice. The drug, which is a generic of Bayer's (BAYN.F) Adempas, is intended for the treatment of chronic thromboembolic pulmonary hypertension in adults and pulmonary arterial hypertension in adults and children.